Background Postoperative microbial keratitis (MK) can cause graft failure and vision loss following keratoplasty for corneal ...
Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts SessionCompany to host investor conference call and webcast during EHA 2026 ...
Industrial transformation isn’t just a technical challenge — it’s a storytelling challenge. Those who master it will move the ...
NDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathwayConfirmatory trial designed to ...
Understood.org, a leading nonprofit supporting the 70 million people in the U.S. who have learning and thinking differences, ...
NDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathway Confirmatory trial designed to demonstrate clinical benefit of mitapivat on reducing ...
Background Joint analyses across multiple health datasets can increase statistical power and improve the generalisability of ...
Introduction For priority populations, such as Indigenous children, school-based screening programmes can increase equitable access to care. However, current traditional economic measures evaluating ...
SUPRAME Phase 3 interim and final analysis for PRAME cell therapy, anzu-cel, expected to be triggered in 2026, advancing toward the Company’s ...
More and more, the real competition between major auction houses involves securing single-owner consignments before ...
As the city embarks once again upon its springtime marathon of fairs and marquee auctions, galleries across Chelsea, Tribeca, ...
Objectives To evaluate the long-term outcomes, clinical phenotypes and factors associated with complications in Still’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results